for patients and Clinicians managing
chronic respiratory conditions

Maximising Leading-Edge Connected Device Technology with our DTx Solutions to Improve Patient Outcomes

Our Smart Sensors + App + Cloud Platform gather data for self-management and telemedicine

FOR DTx TO WORK, ALL STAKEHOLDERS HAVE TO BENEFIT

Patients

DTx puts you in control of your condition. Learning about your body and staying engaged with a chronic disease help you live a full life.

Clinicians

DTx provides you with clinical data on chronic conditions. You can be a lot more confident about therapeutic decisions based on physiological data.

PAYERS

DTx saves you money by reducing admissions and avoiding unnecessary treatment escalation.

Pharma

DTx helps you go beyond the pill. Our tailored solutions increase the impact of your drugs on patients and doctors alike.

Researchers

We build custom apps for respiratory trials and deliver research data on our end-to-end DTx platform.

Pharmacies

Offer DTx solutions to patients collecting prescribed inhalers, to enable them to better self-manage their asthma.

Clinical Programs

We provide Clinical Programs to over 25 ICBs, Trust and Health Boards throughout the UK and Ireland, helping them save money using our end-to-end DTx platform. Get in touch to discuss how we can help your work.

Inhaler DTx

Reliever Inhaler Reduction Programme

Reduce hospital episodes and contribute to the Net Zero by reducing SABA overuse

Details
SABA overuse is a huge problem for patients managing their asthma. Patients using empty inhalers after the medication has run out leads to exacerbations. Lack of dose counter means patients discard half empty inhalers. The Reliever Inhaler Reduction Programme reduces SABA usage and contributes to the Net Zero NHS goals by reducing the amount of discarded inhalers.

 

Preventer Inhaler Adherence Programme

Avoid unnecessary treatment step-ups by improving compliance

Details
Low adherence to preventer inhalers is a huge problem to patients managing their asthma. Whilst some preventer inhalers contain a dose counter, they don’t monitor compliance. The Preventer Inhaler Adherence Programme provides timestamps and average compliance over the last 30 days, leading to improved adherence.

 

Respiratory DTx

Asthma Diagnosis@Home

Diagnose asthma in fewer clinical visits by capturing peak flow variability, symptoms and inhaler use

Details
Asthma is difficult to diagnose, and as a consequence, one third of asthma patients are misdiagnosed or do not have a diagnosis.

Diagnosis requires multiple observations and isn’t conclusive if patients are spirometry or FeNO tested when their asthma is inactive.

The Asthma Diagnosis@Home programme captures peak flow diurnal variability over 7-14 days and records symptoms for 1 month to help confirm or refute diagnosis of suspected asthma, prior to consultation.

ASTHMA MONITORING@HOME

Make data-driven clinical decisions by monitoring asthma control between consultations

Details
At consultations, clinicians only see snapshots of a patient’s asthma, during exacerbations or at a consultation and few patients present usable charts of peak flow diaries. Lack of clinical data leads to increased readmissions. Patients monitored before and after specialist consultation, for 90 days, leads to improved adherence of peak flow and and preventer inhalers and reduced use of reliever inhalers. Exacerbations are reduced by early detection of loss of asthma control. The Asthma Monitoring@Home programme monitors the patient’s asthma between consultations.

 

Asthma Post-ED Monitoring @Home

Reduce readmissions by detecting re-exacerbations for 90 days post-discharge

Details
Patients discharged from ED are usually monitored at home for the first 48 hours. The Asthma Post-ED Monitoring@Home programme monitors the patient for 30 days post-discharge, leading to fewer exacerbations and readmissions to hospital.

 

Asthma Pre-Biologics Screening@Home

Avoid unnecessary referrals for biologics by detecting low adherence

Details
Biologics are expensive and not always the right solution for the patient. Patients with severe asthma are sometimes given biologics where the problem is actually lack of compliance to existing medication. The Asthma Pre-Biologics Screening@Home programme helps identify which patients should be given biologics.

 

SMART SENSORS

Affordable Smart devices connecting to mobile phones

Inhaler DTx

SMART MDI SENSOR

Keeping track of inhaler use

Smart InFlow

Measuring inhaler technique and inspiratory flow

Respiratory DTx

Smart Asthma

Asthma control in your pocket: a small digital peak flow meter

Smart PNIF

Measuring nasal congestion (PNIF)

Patient apps

For self-management and for clinical trials

Inhaler DTx

SMART INHALER APP

Your personal inhaler assistant

Smart InFlow app

Measure how you inhale

Respiratory DTx

Smart Asthma app

Beat flare-ups before you feel them coming

Custom apps for trials

Convenient reporting for Asthma and Rhinitis participants

Cloud platform

Telemedicine dashboard for virtual consultations and for clinical studies

Smart Asthma dashboard

Data-driven Asthma Control. Telemonitoring Lung function, Symptoms, Reliever inhaler use, Asthma control level, CompEx events and more

Smart Peak Flow API

Measure peak flow with your app or your dashboard

SMART MDI SENSOR API

Track inhaler use with your app or your dashboard